Form 8-K - Current report:
SEC Accession No. 0001513162-22-000140
Filing Date
2022-12-09
Accepted
2022-12-09 16:07:25
Documents
13
Period of Report
2022-12-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20221207.htm   iXBRL 8-K 44417
  Complete submission text file 0001513162-22-000140.txt   168611

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20221207.xsd EX-101.SCH 3199
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20221207_def.xml EX-101.DEF 9510
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20221207_lab.xml EX-101.LAB 17478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20221207_pre.xml EX-101.PRE 9749
7 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20221207_htm.xml XML 2204
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 221454839
SIC: 2835 In Vitro & In Vivo Diagnostic Substances